Boston Partners
AMN icon

Boston Partners’s AMN Healthcare AMN Stock Holding History

Boston Partners’s Portfolio AMN Stock Details AMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.2M Buy
2,138,388
+1,103,243
+107% +$21M 0.04% 283
2025
Q4 		$16.3M Buy
1,035,145
+1,021,672
+7,583% +$18.2M 0.02% 386
2025
Q3 		$261K Buy
13,473
+3,370
+33% +$65.8K ﹤0.01% 728
2025
Q2 		$209K Buy
10,103
+17
+0.2% +$353 ﹤0.01% 702
2025
Q1 		$247K Sell
10,086
-1,311,286
-99% -$33.7M ﹤0.01% 684
2024
Q4 		$31.6M Sell
1,321,372
-412,675
-24% -$13.1M 0.04% 281
2024
Q3 		$73.3M Sell
1,734,047
-85,204
-5% -$4.47M 0.09% 222
2024
Q2 		$93.1M Sell
1,819,251
-73,594
-4% -$4.17M 0.12% 211
2024
Q1 		$118M Sell
1,892,845
-991,705
-34% -$67.5M 0.14% 200
2023
Q4 		$216M Buy
2,884,550
+1,461,541
+103% +$105M 0.29% 131
2023
Q3 		$121M Buy
1,423,009
+307,183
+28% +$29.1M 0.17% 177
2023
Q2 		$121M Buy
1,115,826
+783,966
+236% +$74.3M 0.16% 184
2023
Q1 		$27.8M Buy
331,860
+99,268
+43% +$9.35M 0.04% 276
2022
Q4 		$23.8M Buy
232,592
+66,970
+40% +$7.71M 0.03% 284
2022
Q3 		$17.9M Buy
+165,622
New +$18.2M 0.03% 301
2017
Q4 		– Sell
-54,750
Closed -$2.5M – 745
2017
Q3 		$2.5M Sell
54,750
-12,400
-18% -$474K ﹤0.01% 636
2017
Q2 		$2.62M Sell
67,150
-59,450
-47% -$2.28M ﹤0.01% 618
2017
Q1 		$5.14M Sell
126,600
-14,350
-10% -$562K 0.01% 493
2016
Q4 		$5.42M Buy
140,950
+69,620
+98% +$2.38M 0.01% 488
2016
Q3 		$2.27M Buy
+71,330
New +$2.71M ﹤0.01% 644

Other funds holding AMN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Boston Partners's AMN Position: Q1 2026 in Review

Boston Partners increased its AMN Healthcare (AMN) stake by 107% in Q1 2026, buying an estimated $21M and bringing the position to 2,138,388 shares worth $39.2M. The position accounts for 0.04% of the portfolio, ranked #283.

Boston Partners first reported a position in AMN in Q3 2016 and has held it in 20 quarters since. The position peaked at $216M in Q4 2023. 249 funds tracked by Wall St. Rank hold AMN as of Q1 2026.

  • Boston Partners held 2,138,388 shares of AMN Healthcare worth $39.2M as of Q1 2026.
  • Boston Partners bought 1,103,243 AMN Healthcare shares in Q1 2026, an estimated $21M.
  • AMN Healthcare made up 0.04% of Boston Partners's portfolio in Q1 2026, its #283 holding.
  • Boston Partners first reported a position in AMN Healthcare in Q3 2016 and has held it in 20 quarters since.
  • Boston Partners's AMN Healthcare position peaked at $216M in Q4 2023.
  • 249 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2026.

Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.